tirzepatide glp 1 agonist Semaglutide & are transforming diabetes & obesity management. These GLP-1 receptor agonists offer benefits from glycemic control to weight loss and cardiovascular risk reduction, emphasizing their broad impact. Read more from See if you qualify. Major physiological roles of GLP-1

Rybelsus was the first oral GLP-1 approved for diabetes, available in 3mg, 7mg, and 14mg daily tablets

These are context clues, not guaranteesenvironmental, behavioral, and metabolic factors still play major roles

A provider can recommend which type and how much to take based on your unique needs

To Report Adverse Reactions, Contact the FDA: Phone: 1-800-FDA-1088 Online: www.fda.gov/medwatch Disclaimer These statements are intended for informational purposes and do not replace professional medical advice

& Hirsch, E

Lillys Mounjaro (tirzepatide), a GIP/GLP-1 dual agonist, demonstrated cardiovascular protection in landmark head-to-head trial, reinforcing its benefit in patients with type 2 diabetes and heart disease 2025 [Press release]